Autologous saphenous vein is the most commonly used conduit for coronary artery bypass surgery with more than 50% grafts occluding within 10 years. In conventional preparation the vein undergoes considerable surgical trauma with damage to the outer layers during harvesting. Within these regions are situated the vasa vasorum and small vessels providing oxygen and nutrients to the vessel wall. Certain vasa vasorum terminate in the vessel lumen where it is suggested that they have a physiological role. Preservation of the vasa vasorum of saphenous veins used as bypass conduits may play an important role in the maintenance of graft patency.
Get full access to this article
View all access options for this article.
References
1.
Favarolo RG: Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique. J Thorac Cardiovasc Surg58:178-185, 1969.
2.
Gottlob R: The preservation of the venous endothelium by “dissection without touching” and by an atraumatic technique of vascular anastomosis. The importance for arterial and venous surgery. Minnerva Chir32:693-700, 1977.
3.
Rosenfeldt FL, He GW, Buxton BF, et al: Pharmacology of coronary artery bypass grafts. Ann Thorac Surg67:878-888, 1999.
4.
Hausmann H, Merker HJ, Hetzer R: Pressure controlled preparation of the saphenous vein with papaverine for aortocoronary venous bypass. J Card Surg11:155-162, 1996.
5.
Roubos N, Rosenfeldt FL, Richards SM, et al: Improved preservation of saphenous vein grafts by the use of glyceryl trinitrate-verapamil solution during harvesting. Circulation92:1131-1136, 1995.
6.
Souza DSR: A new no-touch preparation technique. Technical notes. Scand J Thorac Cardiovasc Surg30:41-44, 1996.
7.
Souza DSR, Bomfim V, Skoglund H, et al: High early patency of saphenous vein graft for coronary artery bypass harvested with surrounding tissue. Ann Thorac Surg71:797-800, 2002.
8.
Tsui JCS, Dashwood MR: Recent strategies to reduce vein graft occlusion: A need to limit the effect of vascular damage. Eur J Vasc Endovasc Surg23:202-208, 2002.
9.
Souza DSR, Dashwood MR, Tsui JCS, et al: Improved patency in vein grafts harvested with surrounding tissue: Results of a randomised study using three harvesting techniques. Ann Thorac Surg73:1189-1195, 2002.
10.
Lescalie F, Germouty I, Chevalier JM, et al: Entrinsic arterial supply of the great saphenous vein: An anatomical study. Ann Vasc Surg1:273-277, 1986.
11.
Lefebvre D, Lescalie F: Vascularization of the wall of the superficial veins. Anatomy of the vasa vasorum. J Mal Vasc21:C245-C248, 1996.
Barger AC, Beeuwkes R, Lainey LL, et al: Hypothesis: Vasa vasorum and neovascularization of human coronary arteries. N Engl J Med310:175-177, 1984.
14.
Williams JK, Heistad DD: The vasa vasorum of the arteries. J Mal Vasc21(suppl C):266-269, 1996.
15.
Stefanadis C, Vlachopoulos C, Karayannacos P, et al: Effect of vasa vasorum flow on structure and function of the aorta in experimental animals. Circulation92:2669-2678, 1995.
16.
Heistad DD, Armstrong ML, Amundsen S: Blood flow through vasa vasorum in arteries and veins: Effects of luminal PO2. Am J Physiol250:H434-H442, 1986.
17.
Maurice G, Wang X, Lehalle B, et al: Modeling of elastic deformation and vascular resistance of arterial and venous vasa vasorum. J Mal Vasc23:282-288, 1998.
18.
Michel CC: General principles of oxygen transport in the venous wall. J Mal Vasc21:C239-C244, 1996.
Woerner CA: Vasa vasorum of arteries, their demonstration and distribution. In: The Arterial Wall, ed by Lansing AI.Baltimore: Williams and Wilkins, 1959.
21.
Kwon HM, Sangiorgi G, Ritman EL, et al: Adventitial vasa vasorum in balloon-injured coronary arteries: Visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol32:2072-2079, 1998.
22.
Lowenberg RI, Shumacker HB: Morphological observations of normal vasa vasorum. Yale J Biol Med28:395-401, 1940.
23.
Brock WH: Vasa vasorum of veins in dogs and man. Angiology28:351-360, 1977.
24.
Crotty TP: The structure and function of a vascular sphincter at the lateral saphenous vein-planter tributary junction of the dog. Ir J Med Sci157:21, 1988.
25.
Crotty TP: The role of vasa vasorum in atherosclerosis. Med Hypotheses28:233-243, 1989.
26.
Ohta O, Kusaba A: Development of vasa vasorum in the arterially implanted autovein bypass graft and its anastomosis in the dog. Int Angiol16:197-203, 1997.
27.
Crotty TP: The path of retrograde flow from the lumen of the lateral saphenous vein of the dog. Microvasc Res37:119-122, 1989.
28.
Souza DSR: “No-touch” technique harvesting saphenous vein with its surrounding tissue for coronary artery bypass surgery provides an intact endothelium and a high early patency rate. In: Vascular Protection: Molecular Mechanisms, Novel Therapeutic Principles and Clinical Application, ed. by Rubanyi GM, Dzau VJ, Cooke JP.London: Taylor and Francis, 2002, pp 97-106.
29.
Heistad DD, Marcus ML, Law EG, et al: Regulation of blood flow to the aortic media in dogs. J Clin Invest62:133-140, 1978.
30.
Ohhashi A, Ohhashi T: Effects of aortic pressure and vasoactive agents on the vascular resistance of the vasa vasorum in canine isolated thoracic aorta. J Physiol (Lond)453:233-245, 1992.
31.
Heistad DD, Marcus ML, Martins JB: Effects of neural stimuli on blood flow through vasa vasorum in dogs. Circ Res45:615-620, 1979.
32.
Dahm PL, Bodelsson M, Tornenbrandt K, et al: Binding of [3H]-5-hydroxytryptamine to human coronary artery and bypass graft vessels. Cardiovasc Res31:800-806, 1996.
33.
Milner P, Bodin P, Loesch A, et al: Interactions between sensory perivascular nerves and the endothelium in brain microvessels. Int J Microcirc15:1-9, 1995.
34.
Dashwood MR, Mehta D, Izzat MB, et al: Distribution of endothelin-1 (ET) receptors (ET(A) and ET(B)) and immunoreactive ET-1 in porcine saphenous veincarotid artery interposition grafts. Atherosclerosis137:233-242, 1998.
35.
Loesch A, Burnstock G: Immunocytochemistry of vasoactive agents and nitric oxide synthase in vascular endothelial cells with emphasis on the cerebral blood vessels. Cell Vision3:346-357, 1996.
36.
Loesch A, Burnstock G: The endothelium: Electron-immunocytochemistry of vasoactive agents. In: Modern Visualisation of the Endothelium, ed. by Polak JM.Amsterdam: Harwood Academic Publishers, 1988, pp 3-44.
37.
Rothe CF: Venous system: Physiology of the capacitance vessels. In: Handbook of Physiology: Section 2: The Cardiovascular System III, ed. by Sheperd JT, Abboud FM.Bethesda, MD: American Physiology Society, 1983, pp 397-452.
38.
Crotty TP: The vasa vasorum and the paradox of beta-blocker therapy. Med Hypoth37:191-197, 1992.
39.
Herbst WM, Eberle KP, Ozen Y, et al: The innervation of the great saphenous vein: An immunohistochemical study with special regard to regulatory peptides. Vasa21:253-257, 1992.
40.
Tsui JCS, Souza DSR, Filbey D, et al: Localization of nitric oxide synthase in saphenous vein grafts harvested with a novel “no-touch” technique: Potential role of nitric oxide contribution to improved early graft patency rate. J Vasc Surg35:356-362, 2002.
41.
Kamat BR, Galli SJ, Barger AC, et al: Neovascularization and coronary atherosclerotic plaque: Cinematographic localization and quantitative histologic analysis. Hum Pathol18:1036-1042, 1987.
42.
Libby P: Molecular bases of the acute coronary syndromes. Circulation91:2844-2850, 1995.
43.
Kemeny V, Droste DW, Nabavi DG, et al: Collateralization of an occluded internal carotid artery via a vas vasorum—case report. Stroke29:521-523, 1998.
44.
Shimizu H, Tominaga T, Ezura M, et al: Bypass surgery for occluded internal artery revascularization by vasa vasorum-case report. Neurol Med Chir (Tokyo)42:57-61, 2002.
45.
Williams JK, Armstrong ML, Heistad DD: Endothelial denudation stimulates proliferation of vasa vasorum. J Vasc Med Biol2:12-17, 1990.
46.
Wilson SH, Herrmann J, Lerman LO, et al: Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolaemia independent of lipid lowering. Circulation105:415-418, 2002.
47.
Zollikofer CL, Redha FH, Bruhlmann WF, et al: Acute and long-term effects of massive balloon dilatation on the aortic wall and vasa vasorum. Radiology164:145-149, 1987.
48.
Pisco JM, Correia M, Esperance-Pina JA, et al: Changes in vasa vasorum following percutaneous transluminal angioplasty in a canine model of aortic stenosis. J Vasc Interv Radiol5:561-566, 1994.
49.
Cragg AH, Einzig S, Rysavy JA, et al: The vasa vasorum and angioplasty. Radiology148:75-80, 1983.
50.
Eisenhauer AC, Alker K, Kloner R, et al: The effect of balloon angioplasty on vasa vasorum blood flow in canine coronary arteries. Am Heart J120:1285-1291, 1990.
51.
Kwon HM, Sangiorgi G, Ritman EL, et al: Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolaemia. J Clin Invest101:1551-1556, 1998.
52.
Maeng M, Olesen PG, Emmersten NC, et al: Time course of vascular remodelling, formation of neointima and formation of neoadventitia after angioplasty in a porcine model. Coronary Artery Dis12:285-293, 2001.
53.
McGeachie JK, Meager S, Prendergast FJ: Vein-to-artery grafts: The long-term development of neointimal hyperplasia and its relationship to vasa vasorum and sympathetic innervation. Aust NZ J Surg59:59-65, 1989.
54.
Barker SG, Talbot A, Cottam S, et al: Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Arterioscler Thromb13:70-77, 1993.
55.
Martin JF, Booth RF, Moncada S: Arterial wall hypoxia following thrombosis of the vasa vasorum is an initial lesion in atherosclerosis. Eur J Clin Invest21:355-359, 1991.
56.
Bayer IM, Caniggia I, Adamson SL, et al: Experimental angiogensis of arterial vasa vasorum. Cell Tissue Res307:303-313, 2002.
57.
Mehta D, George SJ, Jeremy JY, et al: External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nat Med4:235-239, 1998.
58.
Dashwood MR, Anand R, Loesch A, et al: Vasa vasorum: A system for transporting vasoactive factors in human saphenous vein. J Physiol547P:PC57, 2003.
59.
Stemme V, Swedenborg J, Claesson H, et al: Expression of cyclo-oxygenase-2 in human atherosclerotic coronary arteries. Eur J Vasc Endovasc Surg20:146-152, 2000.
60.
Baker CS, Hall RJ, Evans TJ, et al: Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine, particularly in macrophages. Arterioscler Thromb Vasc Biol19:646-655, 1999.
61.
Kobayashi M, Ito M, Nagagawa A, et al: Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease. Histopathology36:362-371, 2000.
62.
Glas-Greenwalt P, Dalton BC, Astrup T: Localization of tissue plasminogen activator in relation to morphologic changes in human saphenous veins used as coronary artery bypass autografts. Ann Surg181:431-441, 1975.
63.
Shi Q, Wu HD, Sauvage LR, et al: Re-endothelialization of isolated segments of the canine carotid artery with reference to the possible role of the adventitial vasa vasorum. J Vasc Surg12:476-485, 1990.
64.
Loesch A, Milner P, Anglin SC, et al: Ultrastructural localization of nitric oxide synthase, endothelin and binding sites of lectin (from Bandeirea simplicifolia) in the rat carotid artery after balloon catheter injury. J Anat190:93-104, 1997.
65.
Golledge J, Turner RJ, Gosling M, et al: Rapid changes in the coagulant proteins on saphenous vein endothelium in response to arterial flow. Angiology50:693-701, 1999.
66.
Dashwood MR, Barker SGE, Muddle JR, et al: [125I]endothelin-1 binding to vasa vasorum and regions of neovascularization in human and porcine blood vessels: A possible role for endothelin in intimal hyperplasia and atherosclerosis. J Cardiovasc Pharmacol22(suppl 8):S343-S347, 1993.
67.
Herrmann J, Best PJ, Rotman EL, et al: Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Am Coll Cardiol39:1555-1561, 2002.
68.
Kuwahara F, Kai H, Tokuda K, et al: Hypoxia-inducible factor-1a/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension39:46-50, 2002.
69.
Agu O, Hamilton G, Baker DM, et al: Endothelin receptors in the aetiology and pathophysiology of varicose veins. Eur J Vasc Endovasc Surg23:165-171, 2002.
70.
Morbidelli L, Orlando C, Maggi CA, et al: Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am J Physiol269:H686-H695, 1995.
71.
Dawas K, Loizidou M, Shankar A, et al: Angiogenesis in cancer: The role of endothelin-1. Ann R Coll Surg Engl81:306-310, 1999.
72.
André V, Castro C: Antiproliferative strategies for the treatment of vascular proliferative disease. Curr Vasc Pharmacol1:85-98, 2003.
73.
Yla-Herttuala S, Martin JF: Cardiovascular gene therapy. Lancet355:213-222, 2000.
74.
Martin JF: Learning from vascular remodelling. Clin Exp Allergy30(suppl 1):33-36, 2000.
75.
Kalra M, Jost CJ, Severson SR, et al: Adventitial versus intimal liposome-mediated ex vivo transfection of canine saphenous vein with endothelial nitric oxide synthase gene. J Vasc Surg32:1190-1200, 2000.
76.
Tsutsui M, Chen AF, O’Brien T, et al: Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium. Arterioscler Thromb Vasc Biol18:1231-1241, 1998.
